The U.S. biopharmaceutical sector faces cyclical revenue challenges known as the patent cliff, where multiple high-revenue drugs lose exclusivity simultaneously, opening markets to generics and biosimilars. This phenomenon, while causing sharp revenue declines, is integral to the innovation cycle—spurring companies to…
Share This Blog
Ready-to-post copy includes the blog link.
Understanding the Patent Cliff: Its Role in Biopharmaceutical Innovation and Market Dynamics The U.S. biopharmaceutical sector faces cyclical revenue challenges known as the patent cliff, where multiple high-revenue drugs lose exclusivity simultaneously, opening markets to generics and biosimilars. This phenome... Read the full IIPLA blog post: https://iipla.org/blog/understanding-the-patent-cliff-its-role-in-biopharmaceutical-innovation-and-market-dynamics